https://www.selleckchem.com/pr....oducts/bozitinib.htm
Only compound Eh-6 was found to have activity against all Leishmania species. Considering the challenges in anti-leishmanial drug discovery, we developed a multi-species screening assay capable of utilizing non-recombinant parasite strains, and demonstrated its usefulness by screening macrophage-targeting EhPIb-compounds showing their potential for the treatment of cutaneous and visceral leishmaniasis. Previous studies have revealed that high platelet reactivity while on clopidogrel may affect the severe course and worse prognosis of
Like
Comment
Share
